Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF

Table 1

Baseline characteristics for the NLF and LF groups.

Characteristic	NLF group (n = 100)	LF group (n = 25)	Statistics
Age (years)	33.90 ± 8.96	39.83 ± 8.81	t = −2.922	0.004
Gender (male/female)	93/7	23/2	χ^2 = 0.01	0.98
White blood cell count (×10^9/L)	6.04 ± 1.58	6.32 ± 1.72	t = −0.164	0.882
Platelet count (×10^9/L)	184.14 ± 66.67	172.65 ± 58.37	t = −0.397	0.472
ALT (U/L)	1707.26 ± 563.94	1622.13 ± 526.91	t = 0.672	0.503
AST(U/L)	983.26 ± 542.33	1046.79 ± 454.98	t = −0.530	0.597
TBIL (μmol/L)	187.71 ± 103.96	205.45 ± 100.82	t = −0.754	0.452
PT-INR	1.56 ± 0.52	1.68 ± 0.27	t = −1.115	0.267
Creatinine (μmol/L)	68.59 ± 12.69	72.84 ± 12.83	t = −1.026	0.362
HBV-DNA (copies/mL)	1.02e8±1.92e8	7.92e7±7.17e7	t = 0.552	0.582
MELD score	16.66 ± 4.17	18.41 ± 3.64	t = −1.892	0.061
Spleen long diameter (mm)	102.76 ± 13.73	108.93 ± 12.64	t = −1.243	0.237

Data are expressed as the mean ± standard deviation.